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Abstract: A common strategy to increase aggregation resistance is through rational mutagenesis to
supercharge proteins, which leads to high colloidal stability, but often has the undesirable effect of
lowering conformational stability. We show this trade-off can be overcome by using small multivalent
polyphosphate ions, adenosine triphosphate (ATP) and tripolyphosphate (TPP) as excipients. These
ions are equally effective at suppressing aggregation of ovalbumin and bovine serum albumin (BSA)
upon thermal stress as monitored by dynamic and static light scattering. Monomer loss kinetic
studies, combined with measurements of native state protein–protein interactions and ζ-potentials,
indicate the ions reduce aggregate growth by increasing the protein colloidal stability through
binding and overcharging the protein. Out of three additional proteins studied, ribonuclease A
(RNaseA), α-chymotrypsinogen (α-Cgn), and lysozyme, we only observed a reduction in aggregate
growth for RNaseA, although overcharging by the poly-phosphate ions still occurs for lysozyme and
α-Cgn. Because the salts do not alter protein conformational stability, using them as excipients could
be a promising strategy for stabilizing biopharmaceuticals once the protein structural factors that
determine whether multivalent ion binding will increase colloidal stability are better elucidated. Our
findings also have biological implications. Recently, it has been proposed that ATP also plays an
important role in maintaining intracellular biological condensates and preventing protein aggregation
in densely packed cellular environments. We expect electrostatic interactions are a significant factor
in determining the stabilizing ability of ATP towards maintaining proteins in non-dispersed states
in vivo.
Keywords: biopharmaceuticals; protein aggregation; protein–protein interactions; ATP; membrane-
less organelles; protein self assembly
1. Introduction
Next-generation antibody therapeutics include antibody-drug conjugates, multispe-
cific antibodies and antibody fusions are heavily engineered to meet biological efficacy,
but often leading to poor stability and increased propensity to form aggregates, which are
strictly regulated and need to be mitigated against [1–5]. One approach to offset the unde-
sirable behaviour is to increase the protein colloidal stability through protein engineering or
by adding co-solvents to the formulation. However, being successful requires an improved
understanding of native-state protein–protein interactions and the relationship to colloidal
stability, and in turn, understanding the role of colloidal stability in aggregation pathways.
Temperature-induced aggregation resistance can be substantially improved by modu-
lating electrostatic interactions to increase the colloidal stability of the unfolded state. This
has been achieved by developing positive and negative supercharged variants of proteins
by selective mutagenesis of solvent-exposed regions to acidic or basic residues or by attach-
ing acidic amino acids at the N-terminus of an IgG [6–9]. Supercharged variants are more
resistant to heat-induced aggregation and most regain their native structure when cooled
after heat treatment, whereas the wild-type proteins are much more likely to undergo
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irreversible aggregation. However, supercharging causes a decrease in conformational
stability due to intramolecular electrostatic repulsion, which becomes more significant
with an increase in the charged state [10,11]. This trade-off between colloidal stability
and conformational stability also dictates the behaviour of many proteins, in particular
mAbs, under acidic conditions [12–16]. At low pH and low ionic strength conditions, a
large net positive charge causes a reduction in the unfolding free energy, but an increase
in the colloidal stability. The increased colloidal stability predominantly impacts the ag-
gregate growth mechanism leading to slower rates and causing the growth mechanism to
switch from aggregate-aggregate coalescence to growth by monomer addition and then
to nucleation dominated growth where aggregates form but do not grow [14,15,17–20].
However, under acidic conditions, although aggregate growth is suppressed, monomer
loss is greatest due to increased rates of forming non-native aggregation-prone states [14].
Recently it was proposed that the small polyvalent anion adenosine triphosphate (ATP)
plays a role in regulating the formation of membraneless organelles and suppressing protein
aggregation and amyloid formation in the crowded cell environment [21–25]. In addition,
low concentrations (10 mM) of ATP-Mg and its non-hydrolysable analogue APPCP-Mg
prevent heat-induced aggregation of crude egg white and purified egg proteins [22]. The
authors attributed the behaviour to the hydrotropic nature of ATP suggesting the adenosine
group is required to interact with solvent-exposed hydrophobic regions of folded and/or
unfolded proteins and the tri-phosphate moiety provides a protective layer of hydration.
More recently, Mehringer et al. [26] demonstrated that the tri-polyphosphate (TPP) ion
is equally effective as ATP at preventing aggregation of egg proteins and bovine serum
albumin. The authors hypothesised the stabilizing mechanism might originate from the
kosmotropic nature of phosphate groups, which would lead to preventing local exposure
of protein sticky groups upon thermal stress.
In this study, we hypothesize that ATP suppresses protein aggregate growth through
overcharging proteins causing an increase in electrostatic repulsion and colloidal stability.
In contrast to overcharging proteins through mutagenesis, we expect that multivalent ion
binding to proteins will not lead to the trade-off of poor conformational stability against
the increase in colloidal stability. If this is the case, because ATP also binds to proteins
non-specifically [23,27–29], an improved understanding of the electrostatic stabilization
mechanism could lead to a rational strategy for controlling the behaviour for a broad
range of protein types. Along these lines, we have previously shown that lysozyme phase
behaviour can be tuned through non-specific binding of tripolyphosphate (TPP) [30]. At the
same time, we hope to gain more insight into the biological role of ATP towards modulating
protein assembly processes in vivo.
The aggregation behaviour for bovine serum albumin (BSA), ovalbumin, lysozyme,
ribonuclease A (RNaseA), and α-chymotrypsinogen (α-Cgn) has been characterized in
solutions with varying concentrations of ATP, sodium tripolyphosphate (STPP), or NaCl,
which is used as a control for determining the effects of electrostatic screening. ζ-potential
measurements have been used to quantify the extent of protein overcharging through ion
binding, while temperature-ramped dynamic light scattering (DLS) and static light scatter-
ing (SLS) experiments have been used to evaluate how ions influence protein aggregation
behaviour. We have also measured native-state protein–protein interactions in terms of
osmotic second virial coefficients (B22) by static light scattering, characterised the melting
temperature (Tm) using differential scanning fluorimetry (DSF), and carried out monomer
loss kinetics at elevated temperatures.
2. Materials and Methods
2.1. Materials
α-Cgn, BSA, lysozyme, and RNaseA were sourced from Sigma Aldrich (Gillingham,
UK) with purities > 95% and ovalbumin was sourced from MP Biomedicals (Santa Ana,
CA 92707) with a purity > 80%. Tris base, sodium chloride and adenosine triphosphate
(ATP) were sourced from Sigma Aldrich (Gillingham, UK) with purities ≤ 99%. Sodium
Biomedicines 2021, 9, 1646 3 of 19
tripolyphosphate (STPP) was sourced from Fisher Scientific U.K. Ltd., (Loughborough, UK)
with a purity of ≤99%. Water sourced from a Milli-Q® Advantage A10® water purification
system (Merck, Darmstadt, Germany) with a resistivity of 18.2 MΩ.cm was used as the
solvent for all salt and protein solutions.
All buffer solutions used for dialysis and excipient solutions were prepared volu-
metrically and filtered with a 0.2 µm hydrophilic nylon membrane (Merck Millipore Ltd.,
Tullagreen, Ireland). Ionic strength was calculated for each salt using pKa values obtained
from the literature and the Henderson–Hasselbalch equation. A 10 mM tris buffer was
used for all experiments.
2.2. Sample Preparation
Five millilitres of protein stock solution at 15 mg/mL was prepared and dialysed
against 500 mL of the desired buffer for 4 h twice and again overnight at 4 ◦C. After
dialysis, pH was checked and adjusted if necessary to reach the desired value. Protein stock
solutions were passed through a 0.1 µm and then a 0.02 µm Whatman Anotop syringe filter
(Scientific Laboratory Supplies Ltd., Nottingham, UK) and stored on ice. The filtered stock
solutions were used in all the experiments.
A special note on the preparation of ovalbumin should be made. Dynamic light
scattering (DLS) measurements revealed the presence of large aggregates with radii around
100 nm. Prior to dialysis, the aggregates were removed by preparing a dilute ovalbumin
solution (2 mg/mL) in 10 mM tris pH 7.0 buffer, then vacuum filtering the protein solution
with a 0.1 µm Durapore® membrane filter (Merck Millipore Ltd., Tullagreen, Ireland) and
then a 0.025 µm Durapore® membrane filter (Merck Millipore Ltd., Tullagreen, Ireland).
After filtration, the sample was concentrated to 15 mg/mL using a Sartorius 10 kDa MWCO
Vivaspin 20 centrifugal concentration unit (Sigma Aldrich, Gillingham, UK). The protein
solution was then dialysed and filtered as described in the paragraph above.
2.3. ζ-Potential Measurements
ζ-potentials for ovalbumin and α-Cgn were determined on a Zetasizer Nano ZSP
(Malvern Instruments Ltd., Malvern, UK) using DTS1070 folded capillary cells (Malvern
Instruments Ltd., Malvern, UK). All ζ-potential measurements were made with 1 mg/mL
protein concentration at 25 ◦C. The same applied voltage (150 V) was used for all measure-
ments. Henry’s function was set equal to 1.5 according to the Smoluchowski approximation.
The sample was allowed to equilibrate for 120 s before 10 measurements were were col-
lected and averaged. Each sample condition was repeated 3–6 times. Error bars correspond
to the standard deviation across replicate measurements, and in some instances, appear
smaller than the datapoints.
2.4. Temperature Ramped Dynamic Light Scattering (DLS and SLS)
Thermal ramps and isothermal experiments at high temperatures were carried out
on a Wyatt DynaPro NanoStar (Wyatt Technology Corporation, Santa Barbara, CA, USA),
using a laser wavelength of 658 nm, with separate DLS and SLS detectors located at 90◦
to the incident laser light. A sample at a protein concentration of 10 mg/mL and the
target salt concentration was prepared and passed through a 0.02 µm Whatman Anotop
syringe filter (Scientific Laboratory Supplies Ltd., Nottingham, UK). For each experiment,
100 µL of the sample was loaded into a Wyatt 1 µL Quartz Cuvette (Wyatt Technology
Corporation, Santa Barbara, CA, USA). For thermal ramp experiments, the cuvette was
allowed to equilibrate at the starting temperature for 600 s, then heated at 1 ◦C/min from
30–80 ◦C. If significant aggregation occurred before reaching the upper-temperature limit
(80 ◦C), the scan was stopped prematurely to prevent excessive fouling of the cuvette.
For isothermal runs, the loaded cuvette was placed in the cuvette holder after the sample
chamber had reached the target temperature and allowed to equilibrate for 300 s before
taking any readings. For all runs, the acquisition time was set at 6 s, which corresponds to
Biomedicines 2021, 9, 1646 4 of 19
a DLS acquisition being collected every 0.1 ◦C throughout the thermal ramp scans. Each
sample condition was run in duplicate unless otherwise noted.
Intensity autocorrelation functions were analysed using the DYNAMICS software
(Wyatt Technology Corporation, Santa Barbara, CA, USA). Fits to the correlation function
were performed between 1.5 and 6 × 104 µs using a cumulant analysis and regularization
analysis implemented by the DYNAMICS software. The cumulant analysis was used to
determine the z-average hydrodynamic size RH and the polydispersity Pd, which is related
to the gaussian width of decay rates. For ovalbumin and RNaseA samples, a two-decay
model was fit to the intensity autocorrelation function to separate out the contributions
from the monomer and the aggregate. The error bars correspond to the standard deviation
across the replicate measurements.
2.5. Temperature Ramped Thermal Stability to Determine Tm
Protein melting temperatures were measured by monitoring fluorescence as a function
of temperature using an UNcle instrument (Unchained Laboratories, Pleasanton, CA,
USA), which contains a laser with 266 nm wavelength to excite samples. Samples were
equilibrated at 30 ◦C for 5 min before measurements. A 10 µL sample with 1 mg/mL protein
and varying salt concentration was loaded into each microcuvette. Unfolding experiments
were carried out over 30–90 ◦C with a scan rate of 1 ◦C min−1. All measurements were taken
in triplicate. A higher Tm value when changing solution conditions generally indicates
the protein structure is being stabilised. The error bars reported in the results section
correspond to the standard deviation across the triplicate measurements.
2.6. Size Exclusion Chromatography Multiangle Laser Light Scattering (SEC-MALLS)
1 mL samples of 1 mg/mL ovalbumin with the desired STPP or NaCl concentration
in 10 mM Tris pH 7.0 buffer were prepared. These samples were passed through a 0.02 µm
Anotop filter membrane and incubated at 70 ◦C in a water bath for 0, 5, 10, 15, 20 and 30 min
before being removed and placed on ice. Samples were then loaded into an autosampler at
4 ◦C, which was set to inject 100 µL of sample.
Size-exclusion chromatography coupled with multi-angle laser light scattering (SEC-
MALLS) was performed using an Agilent 1100 Series HPLC (Agilent Technologies, Wald-
bronn, Germany) with a Wyatt DAWN EOS (Wyatt Technology Corporation, Santa Barbara,
CA, USA). The Agilent 1110 Series HPLC has a four-line binary pump system, degasser,
temperature-controlled auto-sampler (4–40 ◦C) and 0.6 cm cell Diode Array Detector
(DAD). Protein separation was performed with a TSKgel G3000SWxl column with a 0.5 µm
pre-filter (Tosoh Bioscience LLC, King of Prussia, PA, USA). The aqueous mobile phase
was filtered with a 0.1 µm Durapore® membrane filter (Merck Millipore Ltd., Tullagreen,
Ireland) and consisted of the corresponding TPP or NaCl concentration in 10 mM Tris at
pH 7.0, where a flow rate of 1 mL/min was used. The Wyatt DAWN EOS is an 18-angle
(15–160◦) static light scattering (SLS) instrument. It uses a GaAs laser with a wavelength of
685 nm. The UV signal acquired at 280 nm was simultaneously channelled to the analogue
input on the Wyatt DAWN EOS. The Wyatt Astra 6.1 software (Wyatt Technology Corpora-
tion, Santa Barbara, CA, USA) uses the UV and SLS signals to calculate molecular weights
of eluted species.
2.7. B22 Determination by SLS
SLS experiments were conducted on a Wyatt miniDAWN TREOS 3 angle (49◦, 90◦
and 131◦) detector (Wyatt Technology Corporation, Santa Barbara, CA, USA) and the
Wyatt Calypso II (Wyatt Technology Corporation, Santa Barbara, CA, USA) was used for
automated syringe delivery of the samples. The method and analysis of the SLS data for
obtaining B22 values have been previously described [30,31]. The measurements require a
value for the protein refractive index increment, which was set equal to 0.186 mL/g for
solutions with ovalbumin or α-Cgn. The molecular weights obtained from extrapolating
light scattering data to zero protein concentration agreed within ±1 kDa of the protein
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monomer sequence molecular weight (42.7 kDa for ovalbumin and 25.6 kDa for α-Cgn).
At salt concentrations of either ATP or STPP greater than 5 mM, the measured molecular
weights decrease below monomer value when using 0.186 mL/g for the refractive index
increment. For these runs, the increment was fit to obtain the monomer molecular weight
following the procedure described in Holloway et al. [32]. Results are reported in terms of
a reduced osmotic second virial coefficient given by b22 = B22/Bhs22 where the hard-sphere





ζ-potential measurements shown in Figure 1 were used to determine how NaCl and
STPP influence the net charge of ovalbumin and α-Cgn at pH 7.0. The ζ-potential indicates
the electrostatic potential at the slip plane of the protein, where strongly bound counterions
and co-ions are contained within the surface of hydrodynamic shear. ζ-potential values of
the two proteins tested here at zero salt concentration reflect their net charge at pH 7.0. The
measured isoelectric pH value is 4.6 for ovalbumin, which is expected to have a net negative
charge in the absence of any ion binding, while a slight positive charge is expected for
α-Cgn, which has a pI around 8.3. The ζ-potential measurements for NaCl do not change
much with increasing ionic strength. On the other hand, increasing STPP concentration
causes the ζ-potential for both proteins to become markedly more negative indicating
both proteins are overcharged by TPP binding. Overcharging by TPP has been previously
observed for lysozyme [30] and an intrinsically disordered protein histatin-5 [27], while
similar effects occur for solutions of acidic proteins with salts of trivalent cations [34]. In
these previous studies, the sign of the multivalent ion charge is opposite to the protein net
charge sign. Increasing salt concentration initially leads to protein charge neutralization
followed by the overcharging effect at higher salt concentration. In contrast, in our study,
overcharging effects occur at much lower salt concentration, because α-Cgn is close to its
pI and the net charge sign of ovalbumin is the same as TPP.
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Figure 1. ζ-potential measurements as a function of ionic strength for solutions of ovalbumin
(triangles) or α-Cgn (circles) with either NaCl, STPP, or ATP.
3.2. Thermally Induced Aggregation Experiments
Simultaneous DLS and SLS measurements were made as a function of temperature
for solutions containing either ovalbumin, α-Cgn, or BSA with different concentrations of
NaCl, STPP and ATP. A cumulant analysis was used to determine temperature profiles of
RH, which are shown for ovalbumin (see Figure 2), BSA (see Figure 3a), and α-Cgn (see
Figure 3b) for selected solution conditions (see Figure S1 of the SI for data at all solution
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conditions). The RH of the three proteins remains constant at low temperatures indicating
that the proteins remain in their native states. For all runs at low temperature, RH values of
2.9 nm, 2.5 nm, and 3.8 nm were recorded for ovalbumin, α-Cgn and BSA, which agree with
reported literature values [35–37]. Increasing NaCl concentration causes the aggregation to
shift to higher temperatures for α-Cgn and BSA (see Figure 3a,b, respectively), whereas the
addition of NaCl to ovalbumin causes aggregation to occur more at lower temperatures
(see Figure 2c).
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The effects on ovalbumin aggregation of STPP and ATP follow the same pattern.
In solutions with STPP or ATP, aggregation is shifted to a higher temperature and the
aggregation suppression effects are always greater than for NaCl at equivalent molar
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concentrations. The RH profiles become less curved upon an initial increase in STPP or
ATP concentration, but the dependence is non-monotonic, where minimum curvature
occurs over a concentration range of 5 to 25 mM. Above a concentration of 25 mM, the
curvature remains less than the additive-free solution. Figure 2d shows that the profiles at
salt concentrations of either 10 mM or 50 mM are almost identical for ATP and STPP. The
only discrepancy between ATP and STPP occurs at a salt concentration of 0.5 mM, where
aggregation relative to the buffer solution is enhanced with ATP but suppressed by STPP.
A similar pattern of behaviour occurs for BSA and for ovalbumin in solution with
STPP (compare Figure 2a and the inset to Figure 3a). For both proteins, increasing the
concentration of STPP to 10 mM reduces the curvature in the RH profile. For BSA, further
increasing the salt concentration increases the curvature, but to a lesser extent than observed
with ovalbumin. While we have not measured solutions of BSA with ATP, a recent study
found the aggregation behaviour upon thermal stress as a function of salt concentration is
identical for ATP and STPP at pH 7.4 with a 50 mM Tris buffer [26].
The RH profiles observed with α-Cgn shown in Figure 3b follow a different pattern
when compared with ovalbumin or BSA. For all salts, increasing their concentration shifts
the RH profiles to higher temperatures. However, in contrast to BSA and ovalbumin in
solutions with STPP, for α-Cgn samples, there is always a rapid increase in RH above the
aggregation onset temperature (the temperature where an initial change in RH is detected).
The inset to Figure 3b contains the measured melting temperatures Tm. Increasing STPP
concentration causes a similar increase in the Tm and the aggregation onset temperature,
which indicates the main effect of STPP on aggregate suppression is through stabilizing
α-Cgn against unfolding. Because the slopes of the RH profiles are slightly greater for STPP
containing solutions, we expect the TPP ions are not slowing down aggregate growth. The
aggregation onset temperature is shifted upwards by 1 ◦C for solutions with 100 mM ATP
versus with 100 mM STPP, while similar onset temperatures are observed in solutions with
either 50 mM STPP or 50 mM ATP (see Figure S1 of the SI).
3.3. Analysis of Ovalbumin Thermal Ramp Data Suggests STPP Alters Aggregate Growth Rates
The initial increase in RH with increasing temperature is due to aggregate formation
and growth. To gain further insight into how the salts alter the rates of these steps, we have
fit the electric-field correlation function to a two-decay model given by








where τ is the delay time, q is the magnitude of the scattering vector, fmon and fagg are the
fractions of the light scattered by the monomer and the aggregate, respectively, and Dmon
and Dagg are the diffusion coefficients of the monomer and the aggregate, respectively,
which are related through the Stokes–Einstein relation to the apparent hydrodynamic
sizes, RH,mon and RH,agg, respectively. The accuracy of the fits as characterised in terms
of χ2 values are comparable to the cumulant analysis for the conditions when the ratio
RH,agg/RH,mon < 5. Similar χ2 values are obtained for larger ratios, but the cumulant
analysis is no longer accurate since the population becomes multi-nodal.
In order to check that the fitting parameters have physically realistic values, we
have compared the fit value of fmon against the calculation from the static light scattering
reading, where fmon(T) = Iexmon/Iex(T). Here Iexmon is the excess light scattering intensity
of the sample before aggregation, and Iex(T) corresponds to the intensity as a function
of temperature above the onset of aggregation. The comparison shown in Figure 4a
indicates there is good agreement between the fitting results (shown by symbols) and
the calculations based on the SLS signal (shown by lines). For the run with 10 mM STPP,
it is not possible to obtain accurate estimates for the fit parameters when fmon is small
due to strong correlations between the fitting parameters that arise when RH,agg is only
slightly greater than RH,mon. It should be noted that fmon is roughly proportional to the
inverse of the SLS intensity, which is why it follows the same pattern as the RH profiles
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with respect to the solution conditions. The greatest shift to higher temperatures occurs for
the conditions with 10 mM STPP, while the conditions with 100 mM NaCl are shifted to
lower temperatures.
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i re 4. Results of thermal ramp experiments for ovalb mi solutions from the DLS analysis plotted
versus temperature where salt conditions are shown in the legend. (a) The fraction of light scattering
by the monomer fraction, fmon determined from fitting two-decay model (symbols) and directly
from the measured Iθ (lines). (b) Th polydispersi y Pd determined from the cumulant analysis.
(c) The hydrodynamic radius RH,agg determined from the long-time mode of the two-decay analysis
(symbols) and the RH values from the cumulant analysis (lines). (d) An estimate of the monomer
concentration assuming aggregates have a fractal dimension equal to 1.8 (see text).
The value of RH,agg is a more direct measure of the average aggregate size since RH
corresponds to the average including the monomer population. The fit values of RH,agg
shown in Figur 4c as a function of temperature ca be used to rationalize why there
is a peak in the Pd profiles shown in Figure 4b for the conditions w th STPP. The initial
increase of Pd with te perature occurs along with the c ncomitant increase in when there
is still a significant fraction of the light being scattered by the monomer. The increase
arises because the monomer and the aggregate are contributing to the light scattering
signal. The peak in Pd occurs at a temperature where fmon ≈ 0.3. With further increasing
temperature Pd reduces since the light scattering intensity becomes dominated by the
aggregat s. W en fmon → 0 , Pd reflects the width of he aggregate size distribution, which
remains low for the condition ith 5 to 25 mM STPP (d a only sh wn for 10 mM STPP)
but does increase for the other STPP conditions at the higher temperatures. This provides
some evidence that there could be a cross over in the aggregate growth mechanism when
altering the salt concentration. A low polydispersity of the aggregate distribution is a
signature of growth by chain polymerization, which is most pronounced at intermediate
STPP concentrations, while an increased polydispersity reflects growth by aggregate-
aggregate coalescence [15,38], which is most evident in the absence of STPP. For solutions
with 1 and 100 mM STPP, the increase in Pd above 76 ◦C likely indicates there is some
aggregate-aggregate coalescence.
The results of fitting to the two-decay model can also be used for estimating the
fraction of the protein that is aggregated. The excess normalised scattered light intensity
Iex from the aggregate is given by fagg Iex ∼ caggMagg where cagg and Magg are the mass
concentration of aggregated protein and weight average aggregate molecular weight,
which, in turn, can be approximated from the fit value for the aggregate radius RH,agg
according to Magg ∼ R
d f
H,agg, where d f is the fractal dimension of the aggregate. This
approach is only approximate as d f depends upon a number of parameters such as the
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time evolution of the aggregate, as well as the strength of the electrostatic interactions. The
results are not very sensitive to the choice of d f , which is set equal to 1.8 based on literature
studies of ovalbumin [39]. Figure 4d contains plots of fagg Iex/R
d f
H,agg ∼ cagg which is also
expected to be a measure of the fraction of monomer loss since cagg = c− cmon where cmon
is the mass concentration of the unaggregated protein and c is the concentration used in
the experiment. For the runs with 10 mM STPP, reliable results are only obtainable once
the temperature is greater than ~72.5 ◦C. All the profiles have a similar shape but are offset
from each other with respect to changes in temperature. In particular, the curves for 1 mM
and 10 mM STPP overlay with each other, even though the corresponding RH profiles
differ considerably. This suggests the monomer loss kinetics are similar to each other, but
the aggregate growth is reduced at 10 mM versus 1 mM STPP.
In order to provide a qualitative comparison of monomer loss rates across different
solution conditions, we have defined a monomer loss temperature Tmon as the temperature
where fagg Iex/R
d f
H,agg = 0.006 nm
−1.8 (see Figure 5a). Solutions containing STPP or ATP
over a concentration range of 1 to 10 mM exhibit similar amounts of monomer loss as the
values of Tmon remain relatively constant, although a slight increase of 2 to 3 ◦C occurs
when increasing the salt concentration up to 100 mM. Previous studies on ovalbumin
and charged mutants of ovalbumin indicate monomer loss kinetics under thermal stress
correlate with the protein melting temperature Tm [40]. In Figure 5a, the measured values
of Tm are shown for STPP and for NaCl solutions. For NaCl, there is little variation in Tm
(less than ±1 ◦C) which is consistent with the small variation in the corresponding Tmon
values. Similarly, for STPP solutions, the values of Tm parallel the changes in Tmon. While
we have not measured Tm for STPP concentrations below 10 mM, Mehringer et al. [26]
showed there is only a slight increase of Tm in solutions containing 1 mM STPP relative to
a pH 7.4 buffer solution, while the values remain constant between 1 mM and 40 mM.
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Figure 5. Results from thermal ramp experiments for ovalbumin solutions. (a) A plot of Tm (circles),
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−1.8 (up triangles) referred to as Tmon. (b) The
aggregate size RH,agg as a function of salt concentration. pen, red-shaded, and blue-filled sy bols
c rr s t l, , STPP, respectively.
A relative measure of the aggregate growth rates is given by the aggregate size com-
pared across conditions where there is a similar extent of monomer loss. Figure 5b contains
a plot of RH,agg determined at the monomer loss temperature Tmon. With increasing NaCl
concentration, there is a dramatic increase in the RH,agg values reflecting increased aggre-
gate growth rates. On the other hand, there is a well-defined minimum in the aggregate
growth rate as a function of TPP or ATP concentration. The behaviour observed with
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NaCl follows a similar pattern already observed in the literature, where increasing NaCl
concentration does not alter monomer loss kinetics or conformational stability, but causes
the formation of larger aggregates, an effect which has been attributed to screening of elec-
trostatic repulsion [41,42]. Analogously, a similar finding has been drawn from aggregation
studies of ovalbumin mutants with varying charged states between −1 and −26 e. The
more highly charged mutants form smaller aggregates under low ionic strength conditions,
but under high salt conditions, aggregates become larger and similar-sized to those formed
by the low net-charge mutants [43]. As such, these studies suggest the minimum in aggre-
gate growth rates observed with ATP or TPP should be rationalizable in terms of how the
multivalent ions alter the electrostatic interactions between the aggregating proteins.
There is only a measurable effect of changing from STPP to ATP at a salt concentration
of 0.5 mM. For samples with 0.5 mM ATP, the aggregate growth rates and the monomer
loss kinetics appear to increase relative to the buffer solution. We currently do not have
an explanation for this behaviour, which is opposite to what happens for all other ATP or
STPP-containing solutions.
3.4. SEC-MALLS Measurements Indicate TPP Suppresses Aggregate Growth
We also carried out monomer loss kinetics during isothermal holds at 70 ◦C in a
solution containing either NaCl or STPP to provide further support to the aggregate
growth rates deduced from the thermal ramp experiments. Figure S2 of the SI contains
the chromatograms for the samples heated for 30 min. For each of the runs with STPP, the
chromatograms also contain a peak corresponding to aggregates eluting from the column.
For these samples, the total recovered protein calculated from integrating the aggregate
and monomer peak areas is within 99% of the injected mass indicating negligible amounts
of large aggregates in these samples. For the runs with NaCl, an aggregate peak is not
observed because the aggregated protein is so large that it has been removed by the in-line
filter. Figure 6 contains the monomer fraction and the weight-average molecular weight of
the aggregate peak plotted versus time. The observations that monomer loss is insensitive
to increasing STPP concentration, while aggregate size increases, indicates a concomitant
increase in aggregate growth rates. The decreasing aggregate size observed when using
STPP versus NaCl, or by reducing STPP concentration, is consistent with the trend of
aggregate growth rates deduced from the thermal ramp experiments.
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3.5. RNase A and Lysozyme
We have also used dynamic light scattering to measure the effect of STPP on the
isothermal aggregation of RNAseA at 75 ◦C and pH 7 (10 mM tris buffer) and lysozyme
at 70 ◦C and pH 8.5 (10 mM tris buffer), where the corresponding plots are shown in
Figure 7a,b, respectively. The higher pH has been used for the lysozyme experiment to
lower the temperature required to induce aggregation. RNaseA and lysozyme are expected
to carry a net positive charge under the experimental conditions as their pI values are equal
to 8.6 and 11.3, respectively. Lysozyme experiments could only be carried out at STPP
concentrations greater than 30 mM as the protein was precipitated at lower concentrations.
At 30 mM, the RH profile shifts to a lower temperature than for the buffer solution, while
increasing STPP concentrations above this value shifts the curves to higher temperatures.
However, the slopes of the profiles are similar to each other, so we do not suspect that there
is a strong effect on aggregate growth. On the other hand, for RNaseA, a drastic change
occurs with increasing the STPP concentration from 10 mM to 25 mM. The RH profiles for
25 mM STPP and for 50 mM NaCl are similar to each other. However, when the two-decay
model is applied to the data, we find that the aggregate size for a given RH value is much
greater in the NaCl solutions (see inset to Figure 7a), which indicates a lower aggregate
growth rate in the STPP solutions.
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3.6. b22 Values Indicate ATP/TPP Overcharging Increases Protein–Protein Electrostatic Repulsion
for Ovalbumin, but Not for α-Cgn
To get a better understanding of how the multivalent ions alter the electrostatic interac-
tions between proteins, we have determined the reduced osm tic second virial c efficients
b22 for solutions of either ovalbumin or α-Cgn. Studi s focuse n elucidating aggregation
pathways indicate b22 values s ow a strong correlation with th aggregate growth mech-
nism for a number of mAbs and α-Cgn when varying pH and salt concen ration under
low ionic strength conditions [14,15,17]. b22 measurements, carried out at room temp ra-
ture, reflect native-state protein–pr tein interactions, while aggregate growth likely occurs
through the addition of growth units containing r t i s i p rtially folded states. Th
strong correlation between b22 and aggregate growth mecha ism provides an indication
that the electrostatic interactions between native proteins are similar to those between
aggregate growth units, which might not be surprising since most charged groups occur
on protein surfaces.
Figure 8 shows a plot of the reduced osmotic second virial coefficients b22 values
for ovalbumin and for α-Cgn under the same solution conditions used for monitoring
aggregation upon thermal stress. The independent variable is chosen to be ionic strength,
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which determines the range of electrostatic interactions in terms of the Debye screening
parameter, which at room temperature is given by κ(nm) = 3.29
√
IS(M). At pH 7, the
ionic strength of ATP or STPP solutions is a factor of 9.07 or 9.96 times greater than the salt
concentration, respectively, using the pKa values shown in Figure S3 of the SI [44,45].
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The behaviour for ovalbu in follo s the typical behaviour of proteins in solutions a
fe p units either belo or above the pI, here increasing ionic strength over the range
of 10 to 100 mM screens electrostatic repulsion [31,46–50]. Once the repulsion is sufficiently
screened at higher ionic stre gths, the b22 values are less than 1 reflecting the presence of
attractive protein–protein int ractions. When c a ging the salt from NaCl to STPP, the
increase in b22 at fixed ionic strength suggests there is an increas in the magnitude of
the electrostatic repulsion due to overchargin the protein surface by indi g multivalent
anions, which as also been d duced from the ζ-potential measurements. The increased
protein– repuls on observed in ATP versus STPP olutions exists even at high ionic
strength where electrostatic force re sufficiently screened. As such, it is unclear if ATP
induces a stronger electrostatic repulsion or attenuates the attractive interactions between
proteins, or there is a combination of these two effec s.
t r hand, for α-Cgn, b22 values remain less than 0 for all solution c ditions
reflecting the absence of any electrostatic repulsion, which, for NaCl, is not surprising since
the ζ-potential is r latively small in NaCl solutions. The on-monotonic depen nce of
b22 arises due to the orientational nisotropy f the protein–protein int ractions. C m-
putational studies have shown the main contributions to b22 arise from orientationally
constrained configurations stabilised by protein surfaces with high geometric complemen-
tarity, where the electrostatic interactions are favourable [50–52]. The increase in b22 at low
ionic strength arises from screening these electrostatic interactions. Although ζ-potential
measurements indicate STPP and ATP overcharge α-Cgn, the b22 values are very simi-
lar to the corresponding ones with NaCl when plotted versus ionic strength. This trend
suggests the main effect of STPP is to act as a screening salt and there is no impact of
overcharging on the electrostatic repulsion. The lack of any electrostatic repulsion induced
by ATP or TPP might explain why there is no observed aggregate growth suppression in
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the polyphosphate-containing solutions. When α-Cgn is thermally stressed under low pH
conditions, the transition to aggregate growth by chain polymerization only occurs for
conditions where b22 > 8 [15].
3.7. Aggregate Growth Rates Show Stronger Correlation with FUCHS Factor Than b22
The reduction in aggregate growth rates for ovalbumin occur under conditions where
there is strong electrostatic protein–protein repulsion, but it is not clear why the values of
b22 correlate with aggregate growth rates for NaCl solutions, but not for solutions with
either STPP or ATP. The well-defined minimum in aggregate growth observed for ATP
or STPP is not reproduced by the b22 values. Increasing ATP or TPP concentration to 5 or
10 mM (or equivalently an ionic strength of 50 to 100 mM) has a dramatic effect on reducing
aggregate growth, but the corresponding b22 values are close to 1, which are much less
than the values in the salt-free solution.
Protein aggregate growth rates are more directly related to the FUCHS factor, which
accounts for the effect of the repulsive barrier in the protein–protein interaction potential
under reaction limited cluster association (RLCA) conditions [20,53–56]. The repulsive
barrier slows down the diffusion of primary aggregate units as they collide, which leads to
a reduction in aggregate growth. For isotropic colloids, in the absence of a repulsive barrier,
every collision step leads to aggregate growth. In this case, the inverse of the FUCHS
ratio can be thought of as a sticking probability equal to the fraction of collisions in the
presence of the repulsive barrier normalised by the number of collisions that would have
happened in the absence of a barrier under diffusion-limited cluster association conditions.
For interaction potentials with a range shorter than the size of a monomer, the aggregating








where β is the inverse reduced temperature 1/kBT, where T is temperature and kB is
Boltzmann’s constant, r is the protein centre-to-centre separation, and a is the effective
spherical radius of the protein, which can be approximated by the hydrodynamic radius
(equal to 2.9 nm for ovalbumin). As long as the aggregate morphology remains invariant,
the FUCHS factor is expected to be proportional to the timescale for aggregates to coalesce
with each other assuming the primary aggregating unit can be described by a native protein.
Calculating the FUCHS factor requires fitting a model for the protein–protein inter-
action potential to the measured b22 values. The electrostatic contribution to the interac-
tion potential uel for charged proteins under low ionic strength conditions can be ade-








where lB is the Bjerrum length, Z is the protein net charge. In addition, there are other
attractive contributions to the interaction potential that are not well defined due to the
heterogeneous nature of the protein surface. However, the attractive forces tend to be short-
ranged, in which case the virial coefficient can be approximated by b22 = 1 + bel22 + b
att
22 [31],
where batt22 corresponds to the contributions from attractive interactions, and the electrostatic












The only fitting parameters to the model are the net attractive contribution given by
batt22 and the magnitude of the protein net charge Z, which is assumed to be independent
of salt concentration. In Figure 8a, we show the model calculations for the NaCl data,
assuming that Z is a constant obtained from fitting to the data. The fit value equal to 11.8
e agrees very well with values calculated from the potentiometric titration [57], which
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provides an indication the model is able to capture the electrostatic contribution to the
interaction potential.
A similar approach can be applied to the data obtained for solutions with either ATP
or TPP except the value for Z will reflect the change in protein charge due to ion binding.
As such, we have fit Z to match each b22 value, where the results are presented in Figure 8c.
With increasing salt concentration, the charge parameter remains relatively constant as
expected for NaCl solutions, but there is an increase in Z for both ATP and TPP solutions
reflecting an increase in ion binding. The fit values for ATP solutions are largest reflecting
the increased b22 values.
There is a strong correlation of protein aggregate growth rates with WFUCHS reflecting
the significance of electrostatic interactions. Figure 8d contains the values for WFUCHS
calculated using the fit values of Z, where increasing values of WFUCHS should correlate
with decreased aggregate growth rates. With increasing concentration of ATP or TPP,
there is an increase in WFUCHS. For ATP, the minimum aggregate growth is predicted to
occur above a salt concentration of 1 mM (or ionic strength of about 20 mM). On the other
hand, for STPP solutions, the increase in the FUCHS factor is mainly observed at lower
salt concentrations of 1 to 2.5 mM (ionic strengths of 20 to 36 mM), but the values at 5 to
10 mM STPP concentration are reduced, although these correspond to the minimum in the
aggregate growth rates. Our analysis relies on the applicability of the double layer potential
from DLVO theory to describe the longer-ranged electrostatic interactions between proteins.
However, the potential is derived using the Poisson–Boltzmann equation, which is a mean-
field theory where the ions are treated as an ideal gas. The approximation works well
for salts of monovalent ions but breaks down for multivalent ions due to strong ion–ion
correlations [58,59]. In particular, for asymmetric salts, the screening length κ−1 is over-
estimated when using mean-field theories. In Figure 8a,d, we also show the results of fitting
the double layer potential using a value of κ determined using dressed-ion theory, which
includes the effects of ion correlations [59]. Because the actual range of the potential is
reduced relative to the mean-field prediction, the magnitude of the potential must increase
to match the same b22 value, which is why the fit values of Z and WFUCHS are larger
(see Figure 8c,d). With this correction, the increase in the WFUCHS ratio closely matches
the minimum aggregate growth observed for solutions with STPP concentrations ranging
between 2.5 mM and 10 mM (which corresponds to ionic strengths between 25 and 100 mM).
It is not possible to obtain accurate estimates for the FUCHS ratio at ionic strengths much
greater than 100 mM because values of bel22 become much less than the other contributions
to b22, which amplifies the uncertainty in the fitting parameter Z. However, it is not
surprising that aggregate growth rates decrease at higher salt concentrations. Aggregate
growth suppression occurs due to ion binding, which is saturable, while increased growth
occurs due to ionic screening, which increases monotonically with salt concentration.
The competition between these two effects gives rise to the minimum in the aggregate
growth rates.
Another factor we have neglected is any ion pair formation between sodium and
either ATP or TPP, which would cause the solution to be at a lower ionic strength. We
expect this to be only a minor effect, as measured association constants are on the order of
10 M−1 [60,61], which corresponds to around 0.2% of the polyphosphate ions with bound
sodium at a salt concentration of 10 mM.
For monoclonal antibody solutions, FUCHS ratios have been determined from fitting
aggregate growth models to monomer loss data complemented with aggregate size mea-
surements. The obtained values are on the order of 107 to 109, which is orders of magnitude
greater than expected from DLVO theory indicating there are additional contributions to
the stability of the aggregating units [53,55]. The high stability has been attributed to the
low protein surface coverage of sticky protein aggregation hot spots, which lowers the
likelihood that colliding units stick together. However, our analysis is still applicable if the
primary effect of changing solution conditions on the FUCHS ratio is to alter the interaction
potential, but not the distribution and nature of the aggregation prone regions.
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3.8. ATP Attenuates Native-State Attractive Interactions between Ovalbumin Molecules
The discrepancy that aggregate growth rates are similar for ATP and TPP, while the
measured values of b22 are different from each other, provides more insight into how the
multivalent ions alter the protein–protein interaction potential. According to RLCA theory,
a similar aggregate growth rate implies that the repulsive part of the interaction potential,
which is predominantly determined by electrostatic interactions, is the same for ATP versus
TPP solutions when compared at the same ionic strength. On the other hand, measured
values of b22 are much more sensitive to the contribution from short-ranged attractive
interactions since the integral is related to the Boltzmann factor of the interaction potential.
Taken together, these findings suggest that the difference between ATP and TPP is due to
the effectiveness of ATP in attenuating short-ranged attractive interactions for native-state
ovalbumin, rather than altering repulsive electrostatic interactions. Furthermore, at high
ionic strength, where electrostatic interactions are sufficiently screened, the b22 values for
TPP-containing solution approach the curve to fit the NaCl data indicating similar attractive
protein–protein interactions, while for ATP, b22 ∼ 1 indicating very little protein–protein
attraction. Because a constant short-ranged attractive contribution to b22 has been used
when carrying out the fitting to determine WFUCHS, we expect the results obtained with
STPP are more reliable, while the repulsive barrier will be over-estimated for the ATP
solutions. We also note that the native-state attractive interactions, which are suppressed
by ATP, are not involved in aggregate growth, which supports the general understanding
that growth occurs by the addition of partially unfolded proteins [53,62].
The finding that the barrier in the interaction potential depends only on the electro-
static contribution has further implications for the nature of the attractive interactions.
If attractive protein–protein interactions are isotropic, they should contribute to the bar-
rier in the interaction potential at close separations where the electrostatic repulsion is
greatest. This is especially evident when considering the integral in Equation (1) which
is weighted by r−2. The short-ranged interactions contribute much more to the FUCHS
factor when compared against the integral for b22 which is weighted by r2. As such, it is
much more likely the attractive interactions are anisotropic and constrained to occur in a
limited fraction of the relative orientation space that defines the interaction between a pair
of proteins. If this is the case, attractive interactions will only contribute a small fraction to
the integral for the FUCHS factor. The deduction that attractive interactions are anisotropic
is supported by computational modelling of protein–protein interactions [50–52,63,64] and
phase behaviour studies [65–67], where the shape and location of phase boundaries can
only be captured using anisotropic patchy models for describing proteins.
4. Discussion
By studying five different proteins, we hoped to gain an understanding of protein
structural factors that determine whether ATP or TPP will be effective at reducing aggregate
growth. The strongest suppression occurs with acidic proteins BSA or ovalbumin, where
the initial increase in salt concentrations leads to immediate overcharging since the proteins
already carry a net negative charge at neutral pH. However, the ζ-potential profile for
α-Cgn is very similar to ovalbumin indicating a similar salt concentration is required to
overcharge the protein. As such, it is unlikely the net charge of the protein is the only
factor in determining the aggregation behaviour. For instance, RNaseA aggregate growth
is suppressed, although the suppression occurs at higher salt concentration than observed
for ovalbumin or BSA.
One factor that might play a role is the type of basic residues on the protein surface.
A mutation study of the intrinsically disordered protein Histatin-5 involving all possible
arginine-lysine swap mutants indicated TPP interacts more strongly with arginine versus
lysine groups [27]. The arginine versus lysine mutants are more readily precipitated by
TPP, which was attributed to non-specific TPP binding by arginine groups. Interestingly,
the ζ-potential profiles as a function of TPP concentration are almost identical for all the
mutants indicating TPP also preferentially binds lysine groups, but with a weaker binding
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affinity compared to arginine. Analogously, while non-specific binding of TPP to basic
protein residues likely causes protein overcharging, we hypothesize that a requisite for
electrostatic repulsion is a high content of arginine groups to tightly bind the multivalent
ions. α-Cgn only contains four arginine groups which are distributed unevenly across the
protein surface. However, it is unclear then why TPP does not significantly affect the ag-
gregate growth of lysozyme, which is enriched in arginine groups. There is significant TPP
overcharging of lysozyme by a salt concentration of 10 mM [30], but no aggregate growth
suppression at concentrations of 30 mM and above, even though these concentrations are
effective for RNaseA, ovalbumin and BSA. Lysozyme is precipitated at lower salt concen-
trations due to TPP-induced attractive protein–protein interactions. A distinct possibility is
that these attractive interactions also exist at higher salt concentrations and balance any
electrostatic repulsion arising from TPP overcharging lysozyme. Indeed, the measured b22
values are less than −2 at pH 9 for the salt concentrations used in the aggregation studies
shown in Figure 6 indicating sufficiently strong protein–protein attractions, albeit in the
native state [30].
There has been much focus on determining the mechanism of how ATP alters protein
self-assembly, aggregation, and fibril formation in vivo due to the mM concentrations of
ATP occurring in intracellular environments. Our study supports the work by Mehringer
et al. [26] who showed that TPP and ATP are equally effective at preventing aggregation of
globular proteins, which we have attributed to a supercharging effect through tri-phosphate
binding to basic residues of the protein surface. This mechanism alone cannot explain the
behaviour in vivo since ATP, but not TPP, is effective at suppressing amyloid formation
or solubilizing liquid condensates formed by proteins containing intrinsically-disordered
regions. These effects have been attributed in part to the ability of the adenosine group to
form π–π interactions with sticky aromatic groups [22,25,26,68]. However, we also expect
electrostatic interactions to be a key factor in determining how ATP alters protein assembly
in vivo since the screening length in the cytosolic environment has been estimated to be
around 2.2 nm or an ionic strength of approximately 20 mM [69].
5. Conclusions
The non-specific nature of electrostatic interactions, where increasing protein net
charge almost universally leads to a reduction in aggregate growth rates, suggests that
using small multivalent ions to enhance colloidal stability could be an effective strategy
for stabilizing a broad class of biotherapeutics. However, while the addition of the poly-
phosphate ions always leads to an overcharging effect, this only translates to a reduction
in aggregate growth rates for some of the proteins. As such we still require a better
understanding of the mechanistic effects of the multivalent ions in order to rationalize their
use. Key issues that need to be addressed are why overcharging by ions does not always
lead to an increase in colloidal stability under native conditions, and whether increased
colloidal stability due to overcharging always leads to aggregate growth suppression.
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